Holen Sie sich die Stockscreener-App
1.29
4.44%
-0.06
Schlusskurs vom Vortag:
$1.35
Offen:
$1.34
24-Stunden-Volumen:
88,272
Relative Volume:
0.39
Marktkapitalisierung:
$60.61M
Einnahmen:
$13.18M
Nettoeinkommen (Verlust:
$-9.65M
KGV:
-6.7752
EPS:
-0.1904
Netto-Cashflow:
$-8.58M
1W Leistung:
-3.37%
1M Leistung:
-1.53%
6M Leistung:
+17.27%
1J Leistung:
-31.75%
1-Tages-Spanne:
$1.28
$1.35
1-Wochen-Bereich:
$1.279
$1.389
52-Wochen-Spanne:
$0.99
$2.99
Mindwalk Holdings Corp Stock (HYFT) Company Profile
Firmenname
Mindwalk Holdings Corp
Sektor
Branche
Telefon
-
Adresse
-
Compare HYFT vs VRTX, REGN, ARGX, MRNA, RVMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
HYFT
Mindwalk Holdings Corp
|
1.29 | 63.43M | 13.18M | -9.65M | -8.58M | -0.1904 |
VRTX
Vertex Pharmaceuticals Inc
|
521.27 | 134.06B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
803.01 | 83.43B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
1,004.37 | 63.00B | 4.16B | 1.29B | 734.26M | 19.58 |
MRNA
Moderna Inc
|
137.42 | 56.02B | 2.23B | -3.19B | -1.60B | -8.1462 |
RVMD
Revolution Medicines Inc
|
210.19 | 44.44B | 742.00K | -1.37B | -1.07B | -7.0731 |
Mindwalk Holdings Corp Stock (HYFT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2022-12-02 | Eingeleitet | H.C. Wainwright | Buy |
| 2021-10-25 | Eingeleitet | The Benchmark Company | Buy |
Mindwalk Holdings Corp Aktie (HYFT) Neueste Nachrichten
EBITDA per share of MindWalk Holdings Corp. – HAM:TQB0 - TradingView
HYFT Q1'26 Earnings: EPS estimate is (0.05) USD - TradingView
Top MindWalk (HYFT) Competitors 2026 - MarketBeat
MindWalk (HYFT) schedules Sept. 14 call on Q1 2027 results - Stock Titan
MindWalk Holdings Sets Date for Q1 FY2027 Earnings Call and Webcast - TipRanks
MindWalk Holdings Corp. to Report Financial Results and Recent Business Highlights for First Quarter Fiscal Year 2027 on September 14, 2026 - Yahoo Finance UK
MindWalk Holdings Corp. Statistics – HAM:TQB0 - TradingView
Bio-Native AI therapeutics MindWalk sets March 12 Q3 earnings call - Stock Titan
MindWalk Holdings FY26 Results: Revenue up 46% to C$15.6 million - scanx.trade
The Market Just Told You Which Layer Of AI Biology It Is Paying For - The Manila Times
AI in Drug Discovery Market Projected to Reach $8.52 Billion By 2030 - TradingView
HYFT Q1'26 Earnings: revenue estimate is 3.22M USD - TradingView
MindWalk (HYFT) Momentum: Moves 2.92% Up to $1.41 at the Close; Market Levels: the $1.34 to $1.48 Range Remains in Focus in the Latest ReadingRounding Bottom - siam.in
Most AI Drug Discovery Reads the Genetic Code. The Next Wave Is Learning to Read What the Code Actually Does. - The Manila Times
MindWalk Holdings Corp. (NASDAQ:HYFT) Given Average Recommendation of "Hold" by Analysts - MarketBeat
MindWalk (HYFT) Q2 2026 Results: EPS Misses Its Estimate in the Current Update; Share Response - Vinanet
HYFT News | MINDWALK HOLDINGS CORP (NASDAQ:HYFT) - ChartMill
HYFT Q2 2026 Earnings: EPS Misses Consensus as Loss Reaches -$0.08Earnings Call Q&A - vinanet.vn
MindWalk Holdings (HYFT) Holds Near $1.37 After Modest PullbackMA Cross Alert - Vinanet
AI Found an Influenza Target That Survives Viral Mutation - marketscreener.com
MindWalk AI identifies conserved influenza target surviving mutation - scanx.trade
MindWalk Holdings (HYFT) Edges Up 0.74% as Shares Trade Between $1.29 Support and $1.43 ResistanceUndervalued Stocks - dars.gov.et
HYFT Q2 2026 Earnings: EPS Miss Triggers 4.44% Selloff as Losses Exceed EstimatesMid-Term Outlook - dars.gov.et
MindWalk Holdings Corp. SEC Filing (Jul 31, 2026) - Stock Titan
Zacks Research Downgrades MindWalk (NASDAQ:HYFT) to Strong Sell - MarketBeat
HYFT Q2 2026 Earnings: EPS Misses Estimates Despite Stock UptickEarnings Revision Report - vinanet.vn
MindWalk Holdings (Nasdaq: HYFT) readies $250M shelf for AI-driven growth - Stock Titan
HYFT|MindWalk Holdings Ord Shs|Price:1.440|Chg%:+0.080 - TradingKey
Weekly Recap: Nasdaq compliance, FY26 gains and ReefIQ launch, LensAI deals - TradingView
HC Wainwright Analysts Lower Earnings Estimates for MindWalk - MarketBeat
Q3 2026 MindWalk Holdings Corp Earnings Call Transcript - GuruFocus
MindWalk Holdings Corp. Revenue Breakdown – FWB:TQB0 - TradingView
MindWalk Holdings Corp. 2026 Q4ResultsEarnings Call Presentation (NASDAQ:HYFT) 2026-07-26 - Seeking Alpha
MindWalk Holdings Corp. Revenue Breakdown – NASDAQ:HYFT - TradingView
MindWalk Holdings Corp. Revenue Breakdown – LS:A41GYL - TradingView
HYFT|MindWalk Holdings Ord Shs|Price:1.290|Chg%:-0.060 - TradingKey
MindWalk Holdings Corp. (HYFT) Interactive Stock Chart - Yahoo! Finance Canada
MindWalk Holdings Corp. (NASDAQ:HYFT) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
HYFT Q2 2026 Earnings: EPS Misses Estimates Yet Stock Surges 15% — A Contradictory QuarterSubscription Growth Report - vinanet.vn
MindWalk (NASDAQ:HYFT) Downgraded to Sell Rating by Wall Street Zen - MarketBeat
Mindwalk Holdings Corp. (HYFT) Q3 2026 Earnings ReportResults, Call & Slides - TipRanks
12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga
A Small AI Company Just Took the Stage at One of the Biggest Events in Computing, and It Points to Where Drug Discovery Is Headed - Yahoo Finance
HC Wainwright Estimates MindWalk FY2031 Earnings - MarketBeat
MindWalk Holdings (HYFT) Showcases AI Drug Discovery Platform Us - GuruFocus
Mindwalk Holdings Warns Unreliable Market Data Could Undermine Growth Forecasts and Investor Confidence - TipRanks
HYFT SEC FilingsMindWalk Holdings Corp. 10-K, 10-Q, 8-K Forms - Stock Titan
MindWalk (HYFT) Showcases Innovative AI Drug Discovery Tool at A - GuruFocus
MindWalk demonstrates ReefIQ AI drug discovery platform on AMD By Investing.com - Investing.com Nigeria
MindWalk Showcases ReefIQ™ for AI Drug Discovery at AMD Advancing AI - 01net
MindWalk Holdings Posts 46% Revenue Surge as Pivot to Bio-Native AI Infrastructure Takes Hold - The Globe and Mail
Finanzdaten der Mindwalk Holdings Corp-Aktie (HYFT)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.69%
3.67%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):